Nicotine is a stimulant alkaloid found naturally in the tobacco plant and is the primary psychoactive component of tobacco products. It is commonly used as a recreational drug due to its stimulant and anxiolytic effects, and is also used in some medications for its anxiolytic and antispasmodic effects (Benowitz, 2008).

The pharmacological effects of nicotine are mostly due to its binding to nicotinic acetylcholine receptors (nAChRs) in the brain and peripheral nervous system (PNS). Nicotine has a high affinity for these receptors and stimulates their activity, leading to increased neuronal activity (Viney & Wonnacott, 2008). This stimulation has a number of effects, including increased alertness, improved concentration, and increased heart rate and blood pressure (Benowitz, 2008).

Nicotine also has a number of adverse effects, including addiction, increased risk of cardiovascular disease, and potential negative effects on the developing fetus in pregnant women (Benowitz, 2008). The addictive potential of nicotine is due to its ability to increase dopamine levels in the brain, leading to reward and reinforcement of nicotine use (Balfour & Fagerström, 2004). This effect is further potentiated by the increased availability of nicotine from cigarettes and other tobacco products, resulting in increased levels of nicotine in the blood (Benowitz, 2008).

In addition to its effects on the brain, nicotine also has effects on the body, including increased heart rate, increased blood pressure, and increased risk of stroke and heart attack (Benowitz, 2008). Nicotine also has a number of other adverse effects, including decreased fertility, increased risk of cancer, and a number of other respiratory and gastrointestinal problems (Benowitz, 2008).

It is important to note that while nicotine has a number of beneficial effects, it is also a highly addictive substance with a number of adverse effects. As such, it is important to use nicotine only under the guidance of a healthcare professional and in accordance with the directions on the product packaging.


Balfour, D. J., & Fagerström, K. O. (2004). Nicotine addiction: mechanisms and treatment. International journal of environmental research and public health, 1(1), 17-40.

Benowitz, N. L. (2008). Nicotine safety and toxicity. Oxford University Press.

Viney, E., & Wonnacott, S. (2008). Nicotinic acetylcholine receptors. Current Opinion in Pharmacology, 8(4), 377-387.

Scroll to Top